Molecular predictors of response and survival in patients with relapsed/refractory acute myeloid leukemia following venetoclax plus hypomethylating agent therapy by Isla M. Johnson, Rimal Ilyas, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede H. Begna, Abhishek Mangaonkar, Antoine Saliba, Mark R. Litzow, William Hogan, Mithun Shah, Mrinal M. Patnaik, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat

Get full text

Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatment by Oudai Alkabbani, Yazan Jabban, Rong He, David Viswanatha, Kurt Bessonen, Patricia Greipp, Dragan Jevremovic, James M. Foran, Talha Badar, Cecilia Arana Yi, Yael Kusne, Antoine N. Saliba, Mehrdad Hefazi, Aasiya Matin, William J. Hogan, Abhishek Mangaonkar, Hassan Alkhateeb, Mrinal Patnaik, Mithun Shah, Kebede Begna, Mark R. Litzow, Aref Al-Kali

Get full text

RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm by Chung Hoow Kok, Aref Al-Kali, Daniel Thomas, Rong He, Monika M. Kutyna, Hassan Alkhateeb, Kelly Lim, Antoine N. Saliba, Carla Toop, Aasiya Matin, Hamish Scott, Naseema Gangat, Anna Brown, Abhishek Mangaonkar, Christopher N. Hahn, Kebede Begna, Kevin Hung, Patricia Greipp, William J. Hogan, Mrinal Patnaik, Mithun Shah, Devendra K. Hiwase

Get full text